Navigation Links
Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
Date:1/27/2009

LANSING, Mich., Jan. 27 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that it has entered into an agreement to become the distributor of Chr. Hansen's innovative probiotic feed supplements for the North American swine and poultry markets.

The three-year agreement expands Neogen's comprehensive list of products it offers for the swine and poultry markets, which also includes veterinary instruments, injectables, and its broad line of disinfectants. Under terms of the agreement, Neogen is granted the distributorship of the feed supplements BioPlus(R) 2Bw and GalliPro Tect WS designed for water application in the United States, Mexico, Caribbean, and Central America.

"We believe Christian Hansen is the clear market leader in this arena, and the use of its innovative feed products will continue to grow as swine and poultry producers seek better alternatives to the use of antibiotics to manage disease," said James Herbert, Neogen's chief executive officer. "With our tests for bacterial pathogens, natural toxins in feed grains and antibiotic residues, and our disinfectants and veterinary instruments that we already offer to the swine and poultry markets, Christian Hansen's products are a natural fit to Neogen's overall mission."

BioPlus 2Bw and GalliPro Tect are all-natural feed supplements that contain beneficial probiotic bacteria to naturally help improve swine and poultry feed conversion, and increase weight gain.

"The cooperation with Neogen immediately broadens our access to the swine and poultry integrator market in the U.S., and into Central America and the Caribbean countries. We expect strong growth in sales over the next three years," said Dr. Bill Braman, vice president of marketing and sales, Animal Health & Nutrition, Chr. Hansen NA. "We also see other long-term opportunities with Neogen, such as cooperating to develop additional products for the swine and poultry sectors, and in the dairy and beef cattle segments."

Denmark-based Chr. Hansen is a major distributor of Neogen's line of BetaStar(R) rapid dairy antibiotic tests.

Chr. Hansen is a global biotechnology company that provides ingredients to the food, dairy, human health and nutrition, and animal health industries. Based on intensive research the company is a leading supplier of cultures, probiotics, enzymes and natural colors, which are applied in foods and beverages, dietary supplements, and agricultural products. For more information, visit www.chr-hansen.com.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides. Neogen's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns.


'/>"/>
SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
2. Neogen Reports Best Quarter in Its 26-Year History
3. Neogen Announces New Share Repurchase Program
4. NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
5. Neogen Honored by Forbes; Two Brokerage Firms Initiate Coverage
6. Neogen Reports 26% Increase in Revenues
7. Webcast Alert: Neogen Corporation to Announce 1st Quarter Results
8. NeoGenomics Schedules its Q2 2008 Earnings Release for July 31, 2008
9. Webcast Alert: Neogen Corporation Announces Year-End Results
10. Neogen Acquires Product Line From DuPont Animal Health Solutions
11. Neogen Plans to Double R&D Staff, Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
Breaking Biology Technology:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
Breaking Biology News(10 mins):